PWM
VCYT icon

Parkworth Wealth Management’s Veracyte VCYT Stock Holding History

Parkworth Wealth Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$27 Hold
1
– – ﹤0.01% 1329
2025
Q1 		$30 Hold
1
– – ﹤0.01% 1177
2024
Q4 		$40 Buy
+1
New +$38 ﹤0.01% 1187

Other funds holding VCYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parkworth Wealth Management's VCYT Position: Q2 2025 in Review

Parkworth Wealth Management held its Veracyte (VCYT) position steady in Q2 2025 at 1 share worth $27. The position accounts for ﹤0.01% of the portfolio, ranked #1329.

Parkworth Wealth Management first reported a position in VCYT in Q4 2024 and has held it in 3 quarters since. The position peaked at $40 in Q4 2024. 278 funds tracked by Wall St. Rank hold VCYT as of Q2 2025.

  • Parkworth Wealth Management held 1 share of Veracyte worth $27 as of Q2 2025.
  • Parkworth Wealth Management left its Veracyte share count unchanged in Q2 2025.
  • Veracyte made up ﹤0.01% of Parkworth Wealth Management's portfolio in Q2 2025, its #1329 holding.
  • Parkworth Wealth Management first reported a position in Veracyte in Q4 2024 and has held it in 3 quarters since.
  • Parkworth Wealth Management's Veracyte position peaked at $40 in Q4 2024.
  • 278 funds tracked by Wall St. Rank held Veracyte as of Q2 2025.

Based on Parkworth Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.